Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma.
Fei TengJu-Xiang ZhangQi-Meng ChangXu-Bo WuWei-Guo TangJian-Fa WangJin-Feng FengZi-Ping ZhangZhi-Qiu HuPublished in: Journal of experimental & clinical cancer research : CR (2023)